(Q36734636)

16 August 2017

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer (English)

1 reference

16 August 2017

Yuqiu Jiang

1

1 reference

16 August 2017

Graham Casey

2

1 reference

16 August 2017

Ian C Lavery

3

1 reference

16 August 2017

Yi Zhang

4

1 reference

16 August 2017

Dmitri Talantov

5

1 reference

16 August 2017

Michelle Martin-McGreevy

6

1 reference

16 August 2017

Marek Skacel

7

1 reference

16 August 2017

Elena Manilich

8

1 reference

16 August 2017

Abhijit Mazumder

9

1 reference

16 August 2017

David Atkins

10

1 reference

16 August 2017

Conor P Delaney

11

1 reference

16 August 2017

Yixin Wang

12

1 reference

16 August 2017

language of work or name

1 reference

13 June 2008

1 reference

The Journal of Molecular Diagnostics

16 August 2017

1 reference

16 August 2017

10

1 reference

16 August 2017

4

1 reference

16 August 2017

346-354

1 reference

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Role of genomic markers in colorectal cancer treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Stage II colorectal cancer: to treat or not to treat

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

A gene-expression signature as a predictor of survival in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Gene-expression profiles predict survival of patients with lung adenocarcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

30 September 2017

Focus on colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Gene expression profiling predicts clinical outcome of breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Counting alleles to predict recurrence of early-stage colorectal cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

High density synthetic oligonucleotide arrays

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Tumour markers of prognosis in colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

The DCC protein and prognosis in colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Detection of hepatitis C virus RNA sequences by polymerase chain reaction in fixed liver tissue

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Bias as a threat to the validity of cancer molecular-marker research

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Prognostic factors in colorectal cancer. Literature review for clinical application.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Micrometastases and survival in stage II colorectal cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438204

Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry

5 September 2018

1 reference

12 December 2020

Adjuvant treatment of colorectal cancer

1 reference

12 December 2020

Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer

1 reference

12 December 2020

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

12 December 2020

Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma

1 reference

12 December 2020

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

12 December 2020

Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators

1 reference

12 December 2020

Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers

1 reference

12 December 2020

Stage II colon cancer prognosis prediction by tumor gene expression profiling

1 reference

12 December 2020

10.2353/JMOLDX.2008.080011

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

1 reference